Nasopharyngeal amyloidosis: an unusual cause for epistaxis.
OBJECTIVE
We report the first case of nasal and nasopharyngeal amyloidosis secondary to multiple myeloma; this case also represents the fourth report of systemic nasal or nasopharyngeal amyloidosis.


METHODS
Case report and review of the world literature concerning nasal and nasopharyngeal amyloidosis epidemiology, presentation and management.


RESULTS
Nasal and nasopharyngeal amyloidosis is rare. The presentation, clinical course and treatment are discussed for the presented patient. The amyloid tumour, which recurred in correlation with the progressive transformation of the multiple myeloma, was treated surgically. Subsequent localised radiotherapy decreased the size and growth rate of the tumour.


CONCLUSIONS
Amyloid should be considered as a cause of resistant or recurrent epistaxis provided a mass lesion is seen on radiological imaging. Radiotherapy may be a treatment option in nasal and nasopharyngeal amyloidosis.
Oluk
M A
MA
Department of Haematology, West Wales General Hospital, Carmarthen, Wales, UK. Oluk2000@hotmail.co.uk
Murphy
J
J
D000686:Amyloidosis / Q000150:complications* / Q000175:diagnosis* / Q000628:therapy; D004844:Epistaxis / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications*; D009302:Nasopharyngeal Diseases / Q000150:complications* / Q000175:diagnosis / Q000628:therapy